---

Landmark Research Articles: Non-Surgical Periodontal Therapy (NSPT)

---

SECTION 1: FOUNDATIONAL STUDIES ON SCALING & ROOT PLANING (SRP)

---

1. Badersten, Nilveus & Egelberg (1981, 1984, 1985) - The Classic SRP Series ⭐⭐⭐⭐⭐

• Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy. I. Moderately advanced periodontitis. J Clin Periodontol. 1981;8(1):57–72. (PMID: 6936604)
• Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy. II. Severely advanced periodontitis. J Clin Periodontol. 1984;11(1):63–76.
• Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy. III. Single versus repeated instrumentation. J Clin Periodontol. 1985;12(6):432–440.

• Established that SRP produces statistically and clinically significant reductions in probing pocket depth (PPD) and gains in clinical attachment level (CAL)
• Parts I & II: Demonstrated SRP efficacy in moderately advanced (4-6 mm) and severely advanced (>6 mm) periodontitis - both responded favorably
• Part III: Single instrumentation was as effective as repeated instrumentation at 24 months - questioned the need for repeated sessions
• Proved ultrasonic and hand scalers produce equivalent outcomes

---

2. Listgarten et al. (1978) - Subgingival Microbiota After SRP ⭐⭐⭐⭐

---

3. Cobb CM (1996, 2002) - Definitive Evidence Review of SRP ⭐⭐⭐⭐⭐

• Cobb CM. Non-surgical pocket therapy: mechanical. Ann Periodontol. 1996;1(1):443–490.
• Cobb CM. Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing. J Clin Periodontol. 2002;29(Suppl 2):6–16.

• The 1996 paper is the seminal evidence synthesis quantifying outcomes of mechanical NSPT
• Mean PPD reduction: 1.29 mm (shallow pockets 4-6 mm) to 2.16 mm (deep pockets >7 mm)
• Mean CAL gain: 0.55 mm (shallow) to 1.29 mm (deep)
• Confirmed that SRP is more effective in deeper pockets for CAL gain but may cause recession in shallow pockets

---

4. Morrison et al. / Ramfjord et al. - The Michigan Studies (1980s) ⭐⭐⭐⭐⭐

• Ramfjord SP, Caffesse RG, Morrison EC, et al. 4 modalities of periodontal treatment compared over 5 years. J Clin Periodontol. 1987;14(8):445–452.
• Knowles JW, Burgett FG, Nissle RK, et al. Results of periodontal treatment related to pocket depth and attachment level. Eight years. J Periodontol. 1979;50(5):225–233.

• Ramfjord (1987): Compared SRP, curettage, modified Widman flap (MWF), and osseous surgery over 5 years - SRP and MWF produced comparable results for moderate pockets
• Knowles (1979): 8-year data - SRP produced sustained clinical improvements; results supported maintenance-based care
• Established that pocket depth is the key determinant of treatment modality selection

---

SECTION 2: CRITICAL PROBING DEPTH - THE DECISION THRESHOLD

---

5. Lindhe & Nyman (1975, 1982) - Surgical vs. Non-Surgical, Critical Depth ⭐⭐⭐⭐⭐

• Lindhe J, Nyman S. The effect of plaque control and surgical pocket elimination on the establishment and maintenance of periodontal health. J Clin Periodontol. 1975;2(2):67–79.
• Lindhe J, Westfelt E, Nyman S, et al. Healing following surgical/non-surgical treatment of periodontal disease. J Clin Periodontol. 1982;9(2):115–128.
• Lindhe J, Nyman S, Karring T. Scaling and root planing in shallow pockets. J Clin Periodontol. 1982;9(6):415–418.

• 1975: Demonstrated that plaque control + periodontal therapy (surgical or non-surgical) could maintain the periodontium in health - foundation for cause-related therapy
• 1982 (Healing): Found that both surgical and non-surgical therapy can produce clinical attachment gain, but at different pocket depths
• 1982 (Shallow): SRP in shallow pockets (<3 mm) resulted in attachment loss - the concept of "critical probing depth" at approximately 2.9 mm

---

6. Kaldahl et al. (1993, 1996) ⭐⭐⭐⭐

• Kaldahl WB, Kalkwarf KL, Patil KD, Molvar MP, Dyer JK. Long-term evaluation of periodontal therapy. I. Response to 4 therapeutic modalities. J Periodontol. 1996;67(2):93–102.
• Kaldahl WB, Kalkwarf KL, Patil KD, Molvar MP, Dyer JK. Long-term evaluation of periodontal therapy. II. Incidence of sites breaking down. J Periodontol. 1996;67(2):103–108.

• Compared 4 modalities: SRP, coronal scaling, MWF, osseous surgery
• After 6.5 years: SRP and MWF were comparable for moderate pockets; osseous surgery superior for deep pockets (>7 mm) during maintenance
• Demonstrated that SRP results deteriorate more over long-term maintenance compared to surgery for deep pockets

---

SECTION 3: FULL-MOUTH DISINFECTION

---

7. Quirynen et al. (1995) - Full-Mouth Disinfection (FMD) ⭐⭐⭐⭐⭐

• Introduced the concept of Full-Mouth Disinfection (FMD): all debridement completed within 24 hours + chlorhexidine (CHX) irrigation/rinse
• FMD group showed significantly greater PPD reduction and CAL gain than quadrant-by-quadrant SRP over 2-month intervals
• Rationale: Prevent reinfection of treated sites from untreated reservoirs (tongue, tonsils, saliva)
• Protocol: SRP all pockets within 24 hrs + CHX pocket irrigation + CHX tongue scraping + CHX rinse for 2 months

---

8. Teughels et al. (2009) - FMD vs. Full-Mouth Scaling ⭐⭐⭐⭐

---

SECTION 4: ADJUNCTIVE SYSTEMIC ANTIMICROBIALS

---

9. Haffajee, Socransky & Gunsolley (2003) - Systemic Anti-infective Therapy ⭐⭐⭐⭐⭐

• Comprehensive review of systemic antibiotics as adjuncts to SRP
• Found that metronidazole + amoxicillin combination provided the greatest benefit when added to SRP
• Established that antibiotics should not replace mechanical debridement but supplement it
• Identified aggressive periodontitis as the indication where systemic antibiotics provide the most benefit over SRP alone

---

10. Teughels W, Feres M, Oud V et al. (2020) - EFP S3 Supporting Evidence ⭐⭐⭐⭐⭐

• Additional PPD reduction of ~0.4 mm and CAL gain of ~0.3 mm with systemic antibiotics vs. SRP alone
• Metronidazole ± amoxicillin remains the most evidence-supported combination
• Greatest benefit in Stage III-IV, Grade C periodontitis (formerly severe/aggressive)
• Risk of adverse effects must be weighed; routine use not recommended for all patients

---

11. Khattri et al. (2020) - Cochrane Review: Adjunctive Systemic Antimicrobials ⭐⭐⭐⭐⭐

• Analyzed 45 RCTs; moderate-certainty evidence that adjunctive systemic antibiotics improve PPD and CAL outcomes over SRP alone
• Benefit is modest (0.2-0.5 mm additional PPD reduction)
• Highlighted concern about antibiotic resistance with widespread use

---

SECTION 5: ADJUNCTIVE LOCAL DRUG DELIVERY

---

12. Goodson et al. (1979, 1983, 1985) - Local Drug Delivery Pioneer ⭐⭐⭐⭐⭐

• Goodson JM, Haffajee AD, Socransky SS. Periodontal therapy by local delivery of tetracycline. J Clin Periodontol. 1979;6(2):83–92.
• Goodson JM, Tanner A, McArdle S, et al. Multicenter evaluation of tetracycline fiber therapy. I. Experimental design, methods, and baseline data. J Periodontal Res. 1991;26(3 Pt 2):361–370.

• First demonstrated that antibiotics could be delivered directly to the periodontal pocket (tetracycline-impregnated fibers - Actisite®)
• Achieved local concentrations 100× higher than serum levels achievable by systemic administration
• Led directly to the development of the entire local drug delivery (LDD) system concept for periodontics

---

13. Herrera D, Matesanz P, Martín C et al. (2020) - EFP S3 LDD Review ⭐⭐⭐⭐⭐

• LDD provides additional ~0.4 mm PPD reduction vs. SRP alone
• Strongest evidence for subgingival chlorhexidine chips, doxycycline hyclate gel (Atridox), minocycline microspheres (Arestin)
• Benefits most evident in residual pockets ≥5 mm after initial therapy
• Limited justification for routine first-line use; best as adjunct in residual pockets during supportive therapy

---

14. Hanes PJ & Purvis JP (2003) - Local Anti-infective Agents ⭐⭐⭐⭐

• Systematic review of all available LDD agents: tetracycline fibers, doxycycline gel, minocycline microspheres, metronidazole gel, CHX chip
• All agents demonstrated modest but statistically significant additional PPD reduction (~0.4-0.5 mm) over SRP alone
• Established that no single LDD agent is clearly superior to others

---

SECTION 6: SURGICAL VS. NON-SURGICAL (DECISION-MAKING)

---

15. Heitz-Mayfield LJ, Trombelli L, Heitz F et al. (2002) - Surgical vs. Non-Surgical ⭐⭐⭐⭐⭐

• Surgery produces significantly greater PPD reduction in deep pockets (≥6 mm)
• Non-surgical SRP produces better/equal results in shallow to moderate pockets (≤6 mm)
• In shallow pockets, surgery may cause more recession and attachment loss
• Conclusion: NSPT is the first-line treatment; surgery reserved for residual deep pockets

---

16. Sanz-Sanchez et al. (2020) - Access Flap vs. Subgingival Debridement ⭐⭐⭐⭐

• In initial therapy (Step 2), SRP achieves comparable outcomes to surgery for pockets ≤6 mm
• Confirms surgery should only follow if residual pockets persist after complete NSPT phase
• Reinforces the step-wise treatment approach (treat non-surgically first; reassess; then decide on surgery)

---

SECTION 7: POCKET CLOSURE & TREATMENT OUTCOMES

---

17. Citterio F, Gualini G, Chang M et al. (2022) - Pocket Closure After NSPT ⭐⭐⭐⭐

• After NSPT, ~45% of pockets ≥6 mm resolve to <4 mm (pocket closure)
• ~30% of initially deep pockets remain ≥6 mm (residual pockets requiring further management)
• Established that baseline PPD is the strongest predictor of pocket closure post-SRP

---

SECTION 8: PERIODONTAL-SYSTEMIC CONNECTIONS (NSPT CONTEXT)

---

18. Grossi et al. (1997) - NSPT Reduces HbA1c in Diabetics ⭐⭐⭐⭐⭐

• SRP + doxycycline in type 2 diabetic patients produced a 0.9% reduction in HbA1c at 3 months
• SRP alone produced a modest but non-significant HbA1c reduction
• First strong clinical evidence that treating periodontal disease can improve glycemic control

---

19. Simpson TC et al. (2022) - Cochrane: Periodontal Treatment & Glycemic Control ⭐⭐⭐⭐⭐

• Moderate-certainty evidence: periodontal treatment (SRP) reduces HbA1c by approximately 0.43% at 3-4 months compared to control
• Supports incorporating periodontal therapy into diabetes management protocols
• Effect is clinically meaningful (comparable to some pharmaceutical agents)

---

SECTION 9: CLINICAL PRACTICE GUIDELINES (MANDATORY READING)

---

20. Smiley CJ, Tracy SL, Abt E et al. (2015) - ADA Evidence-Based Guideline ⭐⭐⭐⭐⭐

• Definitive ADA guideline on NSPT
• Strong recommendation for SRP as the primary treatment for chronic periodontitis
• Conditional recommendations for adjuncts: systemic antimicrobials, LDD, photodynamic therapy
• Established evidence-graded recommendations framework for periodontal practice

---

21. Herrera D, Berglundh T, Schwarz F et al. (2023) - EFP S3 Level Guidelines ⭐⭐⭐⭐⭐

• Sanz M, Herrera D, Kebschull M, et al. Treatment of stage I-III periodontitis - The EFP S3 level clinical practice guideline. J Clin Periodontol. 2020;47(Suppl 22):4–60.

• Established the 4-step treatment model: Step 1 (Behavior/Risk Factor Management), Step 2 (Subgingival Instrumentation/SRP), Step 3 (Surgical), Step 4 (Supportive)
• NSPT = Steps 1+2 - these should always be completed before surgery is considered
• SRP remains the cornerstone of cause-related therapy
• Adjuncts (LDD, systemic antibiotics) recommended only in specific indications

---

SECTION 10: ULTRASONIC/SONIC INSTRUMENTATION

---

22. Drisko CL (1998) / Tunkel et al. (2002) - Hand vs. Power Scalers ⭐⭐⭐⭐

• No statistically significant difference in clinical outcomes (PPD, CAL) between hand (curettes) and power-driven (ultrasonic/sonic) scalers
• Power scalers offer advantages: better access to furcations, less operator fatigue, irrigation during procedure
• Both modalities are acceptable standards of care

---

QUICK REFERENCE SUMMARY TABLE

---

EXAMINER'S KEY DATA POINTS TO MEMORIZE